MRI-guided microwave ablation and albumin-bound paclitaxel for lung tumors: Initial experience
- PMID: 36406211
- PMCID: PMC9669312
- DOI: 10.3389/fbioe.2022.1011753
MRI-guided microwave ablation and albumin-bound paclitaxel for lung tumors: Initial experience
Abstract
Magnetic resonance-guided microwave ablation (MRI-guided MWA) is a new, minimally invasive ablation method for cancer. This study sought to analyze the clinical value of MRI-guided MWA in non-small cell lung cancer (NSCLC). We compared the precision, efficiency, and clinical efficacy of treatment in patients who underwent MRI-guided MWA or computed tomography (CT)-guided microwave ablation (CT-guided MWA). Propensity score matching was used on the prospective cohort (MRI-MWA group, n = 45) and the retrospective observational cohort (CT-MWA group, n = 305). To evaluate the advantages and efficacy of MRI-guided MWA, data including the accuracy of needle placement, scan duration, ablation time, total operation time, length of hospital stay, progression-free survival (PFS), and overall survival (OS) were collected and compared between the two groups. The mean number of machine scans required to adjust the needle position was 7.62 ± 1.69 (range 4-12) for the MRI-MWA group and 9.64 ± 2.14 (range 5-16) for the CT-MWA group (p < 0.001). The mean time for antenna placement was comparable between the MRI and CT groups (54.41 ± 12.32 min and 53.03 ± 11.29 min, p = 0.607). The microwave ablation time of the two groups was significantly different (7.62 ± 2.65 min and 9.41 ± 2.86 min, p = 0.017), while the overall procedure time was comparable (91.28 ± 16.69 min vs. 93.41 ± 16.03 min, p = 0.568). The overall complication rate in the MRI-MWA group was significantly lower than in the CT-MWA group (12% vs. 51%, p = 0.185). The median time to progression was longer in the MRI-MWA group than in the CT-MWA group (11 months [95% CI 10.24-11.75] vs. 9 months [95% CI 8.00-9.99], p = 0.0003; hazard ratio 0.3690 [95% CI 0.2159-0.6306]). OS was comparable in both groups (MRI group 26.0 months [95% CI 25.022-26.978] vs. CT group 23.0 months [95% CI 18.646-27.354], p = 0.18). This study provides hitherto-undocumented evidence of the clinical effects of MRI-guided MWA on patients with NSCLC and determines the relative safety and efficiency of MRI- and CT-guided MWA.
Keywords: albumin-bound paclitaxel; magnetic resonance imaging; microwave ablation; non-small cell lung cancer; safety and efficiency.
Copyright © 2022 Shen, Chen, Liu, Yang, Feng, Yu, Zhan, Yin, Wang, Huang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis.Eur Radiol. 2024 Jul;34(7):4708-4715. doi: 10.1007/s00330-023-10510-9. Epub 2023 Dec 20. Eur Radiol. 2024. PMID: 38114848
-
The application of magnetic resonance imaging-guided microwave ablation for lung cancer.J Cancer Res Ther. 2020 Sep;16(5):1014-1019. doi: 10.4103/jcrt.JCRT_354_20. J Cancer Res Ther. 2020. PMID: 33004742
-
The safety and feasibility of three-dimensional visualization planning system for CT-guided microwave ablation of stage I NSCLC (diameter ≤2.5 cm): A pilot study.J Cancer Res Ther. 2023 Feb;19(1):64-70. doi: 10.4103/jcrt.jcrt_2093_22. J Cancer Res Ther. 2023. PMID: 37006044
-
Evaluating the Accuracy and Efficiency of Imaging Modalities in Guiding Ablation for Metastatic Spinal Column Tumors: A Systematic Review.Cancers (Basel). 2024 Nov 25;16(23):3946. doi: 10.3390/cancers16233946. Cancers (Basel). 2024. PMID: 39682134 Free PMC article. Review.
-
Immunomodulatory effects of microwave ablation on malignant tumors.Am J Cancer Res. 2024 Jun 15;14(6):2714-2730. doi: 10.62347/QJID8425. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005685 Free PMC article. Review.
Cited by
-
The Value of Magnetic Resonance Imaging in Assessing Immediate Efficacy After Microwave Ablation of Lung Malignancies.J Thorac Imaging. 2024 Nov 1;39(6):392-398. doi: 10.1097/RTI.0000000000000797. Epub 2024 Jul 18. J Thorac Imaging. 2024. PMID: 39021208 Free PMC article.
-
Surgical Outcomes of Video-Assisted Thoracic Surgery Combined With Computed Tomography-Guided Microwave Ablation for Lung Cancer Presenting as Multiple Ground-Glass Opacities: A 5-Year Retrospective Cohort Study.Thorac Cancer. 2025 Jul;16(14):e70120. doi: 10.1111/1759-7714.70120. Thorac Cancer. 2025. PMID: 40676715 Free PMC article.
-
Advancements in microwave ablation for tumor treatment and future directions.iScience. 2025 Mar 7;28(4):112175. doi: 10.1016/j.isci.2025.112175. eCollection 2025 Apr 18. iScience. 2025. PMID: 40271529 Free PMC article. Review.
-
Nanostrategies synergize with locoregional interventional therapies for boosting antitumor immunity.Bioact Mater. 2025 May 31;51:634-649. doi: 10.1016/j.bioactmat.2025.05.016. eCollection 2025 Sep. Bioact Mater. 2025. PMID: 40521175 Free PMC article.
References
LinkOut - more resources
Full Text Sources